Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency.

about

Eosinophils Contribute to Early Clearance of Pneumocystis murina Infection.Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.

P2860

Q35763497-86853A8B-4902-40CC-84D4-EEF0E3842148 Q41929675-C77F6D0E-EEC8-48C5-991C-A208B36FCD77

P2860

Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency.

Item

http://www.wikidata.org/entity/Q35629437

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Outcomes and duration of Pneum ...... ere combined immunodeficiency.

@ast

Outcomes and duration of Pneum ...... ere combined immunodeficiency.

@en

type

Item

label

Outcomes and duration of Pneum ...... ere combined immunodeficiency.

@ast

Outcomes and duration of Pneum ...... ere combined immunodeficiency.

@en

prefLabel

Outcomes and duration of Pneum ...... ere combined immunodeficiency.

@ast

Outcomes and duration of Pneum ...... ere combined immunodeficiency.

@en

P1476

Outcomes and duration of Pneum ...... ere combined immunodeficiency.

@en

P2093

Ingrid S Lundgren

http://www.w3.org/2001/XMLSchema#string

Janet A Englund

http://www.w3.org/2001/XMLSchema#string

Lauri M Burroughs

http://www.w3.org/2001/XMLSchema#string

Suzanne Skoda-Smith

http://www.w3.org/2001/XMLSchema#string

Troy R Torgerson

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer

Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients

Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency

Severe combined immunodeficiency: a national surveillance study.

Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.

Persistence of Pneumocystis carinii after effective treatment of P. carinii pneumonia is not related to relapse or survival among patients infected with human immunodeficiency virus.

Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group.

Pulmonary diseases in children with severe combined immune deficiency and DiGeorge syndrome.

A Prospective Molecular Surveillance Study Evaluating the Clinical Impact of Community-Acquired Respiratory Viruses in Lung Transplant Recipients

P304

95-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/INF.0B013E31822DB772

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21817949

http://www.w3.org/2001/XMLSchema#string

P932

3244569

http://www.w3.org/2001/XMLSchema#string

Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency.

about

P2860

P2860

Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932